These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 27339626)

  • 1. Properties of bootstrap tests for N-of-1 studies.
    Lin SX; Morrison L; Smith PW; Hargood C; Weal M; Yardley L
    Br J Math Stat Psychol; 2016 Nov; 69(3):276-290. PubMed ID: 27339626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An evaluation of inferential procedures for adaptive clinical trial designs with pre-specified rules for modifying the sample size.
    Levin GP; Emerson SC; Emerson SS
    Biometrics; 2014 Sep; 70(3):556-67. PubMed ID: 24766094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type I errors and power of the parametric bootstrap goodness-of-fit test: full and limited information.
    Tollenaar N; Mooijaart A
    Br J Math Stat Psychol; 2003 Nov; 56(Pt 2):271-88. PubMed ID: 14633336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of small sample size studies using nonparametric bootstrap test with pooled resampling method.
    Dwivedi AK; Mallawaarachchi I; Alvarado LA
    Stat Med; 2017 Jun; 36(14):2187-2205. PubMed ID: 28276584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adaptive Designs with Discrete Test Statistics and Consideration of Overrunning.
    Schmidt R; Burkhardt B; Faldum A
    Methods Inf Med; 2015; 54(5):434-46. PubMed ID: 26429500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parametric bootstrap methods for testing multiplicative terms in GGE and AMMI models.
    Forkman J; Piepho HP
    Biometrics; 2014 Sep; 70(3):639-47. PubMed ID: 24588726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlling the Type I error rate by using the nonparametric bootstrap when comparing means.
    Parra-Frutos I
    Br J Math Stat Psychol; 2014 Feb; 67(1):117-32. PubMed ID: 23647492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sample size and power estimation for studies with health related quality of life outcomes: a comparison of four methods using the SF-36.
    Walters SJ
    Health Qual Life Outcomes; 2004 May; 2():26. PubMed ID: 15161494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of bootstrap methods for estimating sample size and analysing health-related quality of life outcomes.
    Walters SJ; Campbell MJ
    Stat Med; 2005 Apr; 24(7):1075-102. PubMed ID: 15570625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the statistical power for multiple tests: a case study.
    Yeo A; Qu Y
    Pharm Stat; 2009; 8(1):5-11. PubMed ID: 18381588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simplified Estimation and Testing in Unbalanced Repeated Measures Designs.
    Spiess M; Jordan P; Wendt M
    Psychometrika; 2019 Mar; 84(1):212-235. PubMed ID: 29736784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of bootstrap methods for analysing Health-Related Quality of Life outcomes (particularly the SF-36).
    Walters SJ; Campbell MJ
    Health Qual Life Outcomes; 2004 Dec; 2():70. PubMed ID: 15588308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing denominator degrees of freedom approximations for the generalized linear mixed model in analyzing binary outcome in small sample cluster-randomized trials.
    Li P; Redden DT
    BMC Med Res Methodol; 2015 Apr; 15():38. PubMed ID: 25899170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Large sample tests for simultaneous comparison to multiple controls in terms of binomial proportions.
    Soulakova JN; Luo L
    J Biopharm Stat; 2013 May; 23(3):589-603. PubMed ID: 23611197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sample size calculations for population pharmacodynamic experiments involving repeated dichotomous observations.
    Ogungbenro K; Aarons L
    J Biopharm Stat; 2008; 18(6):1212-27. PubMed ID: 18991118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On testing simultaneously non-inferiority in two multiple primary endpoints and superiority in at least one of them.
    Röhmel J; Gerlinger C; Benda N; Läuter J
    Biom J; 2006 Dec; 48(6):916-33. PubMed ID: 17240652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testing non-inferiority of a new treatment in three-arm clinical trials with binary endpoints.
    Tang NS; Yu B; Tang ML
    BMC Med Res Methodol; 2014 Dec; 14():134. PubMed ID: 25524326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonparametric statistical tests for single-case systematic and randomized ABAB…AB and alternating treatment intervention designs: new developments, new directions.
    Levin JR; Ferron JM; Kratochwill TR
    J Sch Psychol; 2012 Oct; 50(5):599-624. PubMed ID: 23040759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization of adaptive designs: efficiency evaluation.
    Menon S; Chang M
    J Biopharm Stat; 2012; 22(4):641-61. PubMed ID: 22651106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-inferiority of new procedure to standard procedure in stratified matched-pair design.
    Nam JM
    Biom J; 2006 Dec; 48(6):966-77. PubMed ID: 17243295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.